by The saliva collection devices market has witnessed significant growth over the past few years owing to the various advantages of saliva testing over conventional blood collection methods. Saliva collection devices are used to collect saliva samples for further testing and analysis. Saliva testing offers non-invasive, painless and convenient methods for testing various diseases and conditions. Moreover, saliva sample collection can be done easily without the need for trained healthcare professionals.
The global saliva collection devices market is estimated to be valued at US$ 342.46 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the saliva collection devices market are IBM Corporation, Oracle Corporation, Cerner Corporation, InterSystems Corporation, Allscripts Healthcare Solutions, Red Hat, Inc. (acquired by IBM), Microsoft Corporation, GE Healthcare, Infor, Inc., Epic Systems Corporation, TIBCO Software Inc., McKesson Corporation, Dell Technologies, Informatica Corporation, Ascom Holding AG.
The key opportunities in the Saliva Collection Devices Market Size include growing adoption of saliva testing in disease screening, drug and alcohol testing, and law enforcement applications. Saliva-based molecular testing offers accurate, cost-effective and scalable methods for large-scale testing.
Growing R&D on advanced saliva collection techniques and integration of IoT and artificial intelligence offers technological advancements in saliva collection devices. Techniques like integrated sensor-based monitoring and computer vision enable automated analysis of saliva samples. Advancing microfluidics also simplify the sample collection process.
Market drivers
The growing demand for non-invasive diagnostic techniques is a major market driver for saliva collection devices. Concerns around pain and infection risks associated with conventional blood drawing methods drive adoption of saliva sample collection. Rising demand for early disease detection using saliva-based molecular testing further supplements the saliva collection devices market growth.
Current challenges in Saliva Collection Devices Market
The saliva collection devices market has demonstrated promising growth over the past few years. However, there are still certain challenges that need to be addressed. One of the key issues is the variable quality of samples collected through different products. Maintaining sample integrity from collection to analysis remains a major challenge. There are also difficulties in standardizing collection procedures and preventing contamination. Further, current products often require a lot of manual handling, which can compromise reproducibility. Affordability is another concern, especially in price-sensitive markets. Manufacturers need to focus on developing low-cost yet high-quality solutions to expand access and uptake.
SWOT Analysis
Strength: Non-invasive nature makes saliva collection less stressful for patients. Also enables easy self-collection and repeat sampling.
Weakness: Difficulties in standardizing collection procedures and preventing contamination. High manual intervention with current products can compromise reproducibility.
Opportunity: Rising demand for liquid biopsy tests and home healthcare presents significant growth prospects. Also scope for innovative automated devices with integrated sample preservation.
Threats: Intense competition from established players and new entrants. Regulatory compliance and affordability remain major challenges especially in emerging markets.
North America accounted for the major share of the global saliva collection devices market in 2023. This is attributed to factors such as the rising adoption of saliva testing across various applications, growing emphasis on preventive healthcare, presence of advanced healthcare infrastructure, and increasing awareness about saliva diagnostics. The market in Asia Pacific is projected to witness the highest growth during the forecast period, owing to the improving healthcare infrastructure, rising healthcare expenditure, and increasing focus on expanded applications of saliva-based tests. China, India, and Japan represent some of the most lucrative country-level markets in the region.
In terms of future growth prospects, the market in Latin America is expected to register strong gains through 2031, driven by the growing adoption of saliva-based testing across Brazil, Mexico, and Argentina. This arises due to the increasing healthcare access coupled with rising per capita income levels in the region. Further, Middle East & Africa presents emerging opportunities for saliva collection device manufacturers, supported by the improving diagnostic capabilities and expanding healthcare reforms.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
